Allan Bibak

Allan Bibak, Ph.D has a varied work experience spanning over two decades. Currently, they are employed as a Tec Transfer Scientist at Bavarian Nordic since February 2023. Prior to this, from February 2022 to February 2023, they worked as a Senior Pharma Consultant at Pharma IT. Before this, they served as an Evening & Night Shift Manager at AGC Biologics from May 2021 to January 2022.

From 2017 to 2021, Allan worked at Xellia Pharmaceuticals as a Specialist QC. Before that, they were employed as an Academic at Statens Serum Institut from May 2015 to January 2017.

During their tenure at Kem-En-Tec Diagnostics A/S from October 2013 to April 2015, Allan held the position of QA/QC Manager, with responsibilities including overall quality assurance, development and maintenance of the QAS system, and overall management of Quality Control (QC).

From 2010 to 2013, they worked at Region Sjælland as a QC-Leader, responsible for managing two QC laboratories and developing analysis methods in the area of pharmacy.

Earlier in their career, Allan served as a QC/QA Manager at Hevesy Laboratory, Risø from December 2006 to January 2010, where they were responsible for method development, validations, and quality control of radiopharmaceuticals.

Prior to that, they were employed as a Method Development Chemist at Højvang Miljø laboratorium from January 2003 to December 2006. In this role, they were responsible for method development, validations, and quality system maintenance.

Allan's earliest role was as a Team Leader-QC at Novo Nordisk from May 2001 to September 2003. Allan 'sresponsibilities included general analysis of Factor VII and ensuring compliance with regulations, documentation, and procedures.

Allan Bibak, Ph.D, obtained their education from Den Kgl. Veterinær- og Landbohøjskole, where they pursued a Doctor of Philosophy - PhD degree in Jordbrugsvidenskab og agronomi generelt. Allan completed their studies from 1990 to 1994. Allan also holds a certification in GAMP5 & Computer System Validation (CSV) Basics, which they obtained in September 2022 from Pharma IT.